His primary scientific interests are in Immunology, Hepatitis C virus, Interleukin 21, Hepatitis C and Virology. His Immunology study frequently draws connections to adjacent fields such as Genotype. His studies in Interleukin 21 integrate themes in fields like Natural killer cell and Interleukin 12.
He has included themes like Ribavirin and Hepatitis in his Hepatitis C study. Jacob Nattermann does research in Virology, focusing on Hepacivirus specifically. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Acquired immunodeficiency syndrome.
Jacob Nattermann mainly focuses on Immunology, Virology, Hepatitis C virus, Internal medicine and Hepatitis C. As a member of one scientific family, Jacob Nattermann mostly works in the field of Immunology, focusing on Genotype and, on occasion, Allele. His Virology research incorporates themes from Epitope, CD8 and Antigen.
His Hepatitis C virus course of study focuses on Human leukocyte antigen and Viral evolution. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology. The Hepatitis C study combines topics in areas such as Viral hepatitis, Apoptosis and Hepatitis.
His scientific interests lie mostly in Internal medicine, Immunology, Gastroenterology, Cancer and Immune system. His studies deal with areas such as Oncology and Hereditary diffuse gastric cancer as well as Internal medicine. His work on CD14 as part of general Immunology study is frequently linked to Sample collection, therefore connecting diverse disciplines of science.
Within one scientific family, Jacob Nattermann focuses on topics pertaining to Antibiotics under Gastroenterology, and may sometimes address concerns connected to Autoimmune hepatitis and Chronic liver disease. His work on Lynch syndrome as part of general Cancer study is frequently connected to Indigo carmine, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Immune system study combines topics from a wide range of disciplines, such as Myeloid, Peripheral blood mononuclear cell, Pathogenesis and Respiratory failure.
Jacob Nattermann mostly deals with Immune system, Immunology, Transcriptome, Respiratory failure and Internal medicine. His Immune system research integrates issues from Myeloid, Peripheral blood mononuclear cell, Erythropoiesis and Pathogenesis. Jacob Nattermann interconnects Gene signature and CD11c in the investigation of issues within Myeloid.
Jacob Nattermann studies Virus which is a part of Immunology. In his research, Severity of illness and Case-control study is intimately related to Whole blood, which falls under the overarching field of Transcriptome. His Internal medicine study often links to related topics such as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
Jonas Schulte-Schrepping;Nico Reusch;Daniela Paclik;Kevin Baßler.
Cell (2020)
A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice
Hans L. Tillmann;Alex J. Thompson;Keyur Patel;Manfred Wiese.
Gastroenterology (2010)
Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis
Henning W. Zimmermann;Sebastian Seidler;Jacob Nattermann;Nikolaus Gassler.
PLOS ONE (2010)
Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C
Jacob Nattermann;Georg Feldmann;Golo Ahlenstiel;Bettina Langhans.
Gut (2006)
Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
Henning W. Zimmermann;Sebastian Seidler;Nikolaus Gassler;Jacob Nattermann.
PLOS ONE (2011)
The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells
Jacob Nattermann;Hans Dieter Nischalke;Valeska Hofmeister;Golo Ahlenstiel.
American Journal of Pathology (2005)
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
Janet P Tate;Amy C Justice;Michael D Hughes;Fabrice Bonnet.
AIDS (2013)
The VACS Index
Janet P Tate;Amy C Justice;Michael D Hughes;Fabrice Bonnet.
AIDS (2013)
Interferon-lambda serum levels in hepatitis C.
Bettina Langhans;Bernd Kupfer;Ingrid Braunschweiger;Simone Arndt.
Journal of Hepatology (2011)
IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study
Vijayaprakash Suppiah;Silvana Gaudieri;Nicola J. Armstrong;Kate S. O'Connor.
PLOS Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bonn
University of Bonn
University Hospital Bonn
University Hospital Bonn
University of Bonn
University of Bonn
Leipzig University
University of New South Wales
University of Sydney
University of Nottingham
Tampere University
Paul Scherrer Institute
Vrije Universiteit Amsterdam
University of North Carolina at Chapel Hill
Institut National de la Recherche Scientifique
University of Helsinki
University Medical Center New Orleans
University of Toronto
Goddard Institute for Space Studies
University of Aveiro
Missouri University of Science and Technology
National Institute of Allergy and Infectious Diseases
Virginia Commonwealth University
Kyoto University
Children's Hospital of Philadelphia
University of Cambridge